Metformin is best taken with meals to reduce gastrointestinal discomfort. Taking it on an empty stomach may increase the likelihood of nausea and diarrhoea.
Take the missed dose with the next main meal according to the local time zone; do not take a double dose to “catch up.”
Yes, tablets often vary in colour, size, or imprint to identify strength (e.g., 500 mg tablets may be white, while 850 mg tablets might be pink). Check the pharmacy label for specific identifiers.
Metformin is not a prohibited substance and does not typically appear on standard workplace drug screening panels.
Metformin is excreted in breast milk in small amounts. Current evidence suggests it is generally safe, but the decision should be made with a healthcare professional weighing maternal benefits and infant exposure.
Metformin is often combined with agents such as sulfonylureas, DPP-4 inhibitors, or insulin. Combination therapy should be prescribed by a clinician who can monitor for additive effects and hypoglycaemia risk.
The metallic taste is a common, transient side effect related to the drug’s impact on taste receptors and gastrointestinal tract; it usually resolves with continued use.
Store at room temperature, typically between 15 °C and 30 °C, away from moisture and direct sunlight.
Renal function should be assessed at baseline, then at least annually; more frequent monitoring is advised if eGFR is below 60 mL/min/1.73 m² or if other risk factors are present.
Metformin may produce modest weight loss in some patients with type 2 diabetes, primarily due to improved insulin sensitivity and reduced appetite, but it is not a primary weight-loss medication.
This article covers Metformin, available as a generic medication and marketed under brand names such as Glucophage, Glumetza, and Siofor. Metformin is classified as an oral antihyperglycaemic agent in the biguanide class and is used primarily to manage type 2 diabetes mellitus. It is supplied as a pill in strengths of 500 mg, 850 mg, and 1000 mg and is prescribed in the United Kingdom under the authority of the MHRA (Medicines and Healthcare products Regulatory Agency).
Metformin reduces hepatic glucose production, enhances insulin-mediated peripheral glucose uptake, and modestly delays intestinal carbohydrate absorption. By inhibiting mitochondrial respiratory-chain complex 1, it lowers intracellular ATP levels, which activates AMP-activated protein kinase (AMPK). AMPK activation decreases gluconeogenesis in the liver and improves insulin sensitivity in muscle tissue. The drug’s onset of action occurs within a few days, with maximal glucose-lowering effect typically reached after several weeks of consistent dosing. Its oral bioavailability is approximately 50-60 %, and it is not metabolised; the unchanged drug is excreted unchanged by the kidneys.
Metformin is approved in the UK for the following indications:
It is generally prescribed for patients with a body mass index (BMI) ≥ 25 kg/m², though clinicians may individualise therapy based on clinical judgement.
Current peer-reviewed evidence supports the following off-label applications, none of which are approved by the MHRA:
Off-label use requires medical supervision and individualized risk assessment.
Absolute contraindications
Relative contraindications
Special populations
Major interactions
Iodinated contrast agents - may precipitate renal dysfunction; temporarily discontinue metformin.
Cimetidine - can increase metformin plasma concentrations; monitor for toxicity.
Moderate interactions
Loop diuretics (e.g., furosemide) - may reduce renal clearance of metformin; adjust dose if renal function declines.
Beta-blockers - can mask hypoglycaemia symptoms when metformin is combined with insulin or sulfonylureas.
Patients should disclose all medications, supplements, and herbal products to their healthcare provider before initiating metformin.
This article provides educational information about Metformin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
